newsfilter
← Latest News
GlobeNewswire·

Zogenix Product FINTEPLA® (Fenfluramine) Recognized for Setting a New Standard for Dravet Syndrome Treatment Outcomes

In Epilepsy & Behavior editorial, authors write that FINTEPLA data demonstrate "unprecedented level of seizure control" for treated patients living with Dravet syndrome, a severe, debilitating childhood-onset epilepsy. Authors also recognize FINTEPLA f